Acadia Pharmaceuticals (ACAD) Stock
Acadia Pharmaceuticals (ACAD) closed at $18.32 on Nov 17, 2026; its Tenet Score is 65 of 100 against 340 Healthcare peers.
7 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $18.32
- Nov 17, 2026
- Market cap
- $3.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 9.0×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 15.86 – 30.96
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 65/100
- Solid · 340 Healthcare peers
Industry: Drugs
Acadia Pharmaceuticals Inc scores 65/100. Solid. Strongest on financial health and quality, trading at 9× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✕ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ~ Graham Defensive
- ✕ Quality Compounder
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treat…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Enliven Therapeutics IncELVN | 60 | $3.5B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.5B |
| Arcutis Biotherapeutics IncARQT | 43 | $3.4B |
| Viking Therapeutics IncVKTX | 36 | $3.4B |
| Supernus Inc.SUPN | 53 | $3.4B |
| Bausch Health Companies IncBHC | 51 | $3.2B |
| Dyne Therapeutics IncDYN | 52 | $3.1B |
| Xeris Biopharma Holdings IncXERS | 48 | $3.1B |
| Adma Biologics IncADMA | 72 | $3.0B |
| Ideaya Biosciences IncIDYA | 57 | $2.9B |
Common questions
What sector and industry is Acadia Pharmaceuticals in?
Acadia Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Acadia Pharmaceuticals' Tenet Score?
Acadia Pharmaceuticals' Tenet Score is 65 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




